What Key Growth Drivers Are Shaping The Genome Editing/Genome Engineering Market Forecast Toward $20.64 Billion?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Much Will The Genome Editing/Genome Engineering Market Be Worth By 2029?
The market size for genome editing/genome engineering has seen accelerated growth over the last few years. The market, valued at $8.62 billion in 2024, is expected to reach $10.17 billion in 2025 with a compound annual growth rate (CAGR) of 17.9%. The robust growth witnessed during this historical period can be credited to factors such as intensified research in the field of genetics and genomics, increasing instances of genetic diseases, advancements in gene therapy techniques, significant investments channelled towards biotechnology and life sciences, potential applications in agriculture, and usage in model organisms.
The market size of genome editing/genome engineering is predicted to undergo swift expansion in the coming years. The market is anticipated to escalate to $20.64 billion in 2029, with a compound annual growth rate (CAGR) of 19.4%. Factors contributing to this growth during the forecast period include the advent of prime editing, the concentration on ethical and regulatory infrastructures, its increasing use in drug exploration, its therapeutic potential for genetic ailments, its customization for gene functionality studies, and the rising interest in epigenome editing. Key trends within the projected period encompass advancements in Crispr technology, increasing applications in therapeutic practices, the introduction of new genome editing tools, higher levels of investments and partnerships, improved delivery systems, and the incorporation of artificial intelligence (AI) in genome editing design.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8010&type=smp
What Market Forces Are Contributing To The Growth Of The Genome Editing/Genome Engineering Market?
The escalating incidences of cancer and other genetic anomalies are anticipated to spur the expansion of the genome editing/genome engineering market. Cancer occurs when some of the body’s cells proliferate uncontrollably and invade other parts of the body. Genome editing has the potential to rapidly modify immune cells and oncolytic viruses for use in cancer treatments. For instance, the World Health Organization (WHO), a United Nations health agency based in Switzerland, disclosed in an article from February 2022 that almost 10 million deaths, equivalent to nearly one in six, were due to cancer, thereby ranking it as the world’s leading cause of mortality. Further, according to a report released by the Centers for Disease Control and Prevention (CDC) in June 2022, a US-based national public health agency reported that in 2019, the US saw 1,752,735 new instances of invasive cancer overall, comprising 863,830 women and 888,905 men. The overall cancer incidence rate was noted to be 439 per 100,000 people. Accordingly, the increasing instances of cancer and other genetic anomalies are facilitating the expansion of the genome editing and genome engineering market.
Which Segments Define The Structure Of The Genome Editing/Genome Engineering Market?
The genome editing/genome engineeringmarket covered in this report is segmented –
1) By Product And Service: Reagents And Consumables; Software And systems; Services
2) By Technology: CRISPR; TALEN; ZFN; Antisense; Other Technologies
3) By Application: Cell Line Engineering; Genetic Engineering; Diagnostic Applications; Drug Discovery And Development; Other Applications
4) By End User: Biotechnology Companies; Pharmaceutical Companies; Academic And Government Research Institutes
Subsegments:
1) By Reagents And Consumables: CRISPR Or Cas9 Kits; TALENs Kits; Zinc Finger Nucleases (ZFNs); Donor DNA Templates; Nucleotide Reagents
2) By Software And Systems: Genome Editing Design Software; Analysis And Visualization Tools; Workflow Management Systems
3) By Services: Gene Synthesis And Cloning Services; Custom Genome Editing Services; Consulting Services For Genome Editing Projects
Which Disruptive Trends Are Driving Change Across The Genome Editing/Genome Engineering Market?
The trend of major technological strides in gene editing is gaining steam in the genome editing/genome engineering market. Major market players are focusing on devising novel technology solutions to enhance their standing. For instance, in May 2022, a joint endeavor between Kyoto University and the Institute of Evolutionary Biology (CSIC-Universitat Pompeu Fabra), a Spain-based research institution that specializes in evolutionary biology, introduced a fast and efficient technique for gene editing in insects. This method, named Direct parental CRISPR (DIPA-CRISPR), involves the injection of substances into growing eggs within adult females, rather than directly into embryos. This groundbreaking method allows researchers to circumvent the process of microinjecting CRISPR material into insect embryos.
Which Firms Are Making The Biggest Impact In The Genome Editing/Genome Engineering Market?
Major companies operating in the genome editing/genome engineering market are Thermo Fisher Scientific Inc., Merck Group, Genscript Biotech Corp, Sangamo Therapeutics Inc., Lonza Group AG, Editas Medicine Inc., CRISPR Therapeutics AG, Agilent Technologies Inc., Intellia Therapeutics, bluebird bio Inc., Transposagen Biopharmaceuticals Inc., Tecan Trading AG, Precision BioSciences, PerkinElmer Inc., Cellectis S.A, Applied StemCell Inc., Bio-Rad Laboratories Inc., Bio-Techne, Creative Biogene, Cyagen Biosciences, Dharmacon Inc., Eurofins Genomics LLC, Evotec SE, GeneCopoeia Inc., Genewiz, Horizon Discovery Group PLC, Inscripta Inc., Integrated DNA Technologies Inc., MaxCyte Inc., New England Biolabs, Novartis International AG.
Access The Complete Report Here:
Which Region Is Forecasted To Lead The Genome Editing/Genome Engineering Market In The Coming Years?
North America was the largest region in the gene editing/genome engineering market in 2024. Asia-Pacific is expected to be the fastest-growing region in the genome editing/genome engineering market report during the forecast period. The regions covered in the genome editing/genome engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=8010&type=smp
Browse Through More Reports Similar to the Global Genome Editing/Genome Engineering Market 2025, By The Business Research Company
Gene Editing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report
Genes Therapy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report
Cell And Genes Therapy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
